Atlas Trials

Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml

Clinical trial NCT01985373 · COMPLETED

Trial details

NCT number
NCT01985373
Sponsor
Prothya Biosolutions
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Immunodeficiency
Start date
2013-12-01
Primary completion
2015-03-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.